Breaking News, Collaborations & Alliances

GenScript, Selecxine Enter Biologics Partnership

Agreement features innovative antibody drug development.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The contract development and manufacturing business segment of GenScript has partnered with Korean biotech Selecxine on innovative antibody drug development.   According to the agreement, GenScript will be responsible for preclinical pharmacy research and IND filing in Selecxine’s project. This project is based on cytokine-antibody complexes. Compared with classic monoclonal antibody and protein drug, this project provides a new insight into new drug development, according to the company. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters